NEW YORK (
) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally poor debt management and disappointing return on equity.
MedAssets, Inc. provides technology enabled products and services for hospitals, health systems, and ancillary healthcare providers in the United States. The company has a P/E ratio of 21.9, below the average computer software & services industry P/E ratio of 44.8 and below the S&P 500 P/E ratio of 22.6. MedAssets has a market cap of $1.2 billion and is part of the
industry. Shares are up 5.6% year to date as of the close of trading on Thursday.
You can view the full
or get investment ideas from our